Endoscopic procedures have been well-documented in the obesity field, but have not yet reached a sufficient level of evidence as stand-alone methods for treating obesity. It is unclear if they should take over. Although expanding, the array of bariatric surgical techniques does not fully meet the current needs, and there are not enough resources for increasing surgery. Surgery is avoided by a majority of patients, so that less aggressive procedures are necessary. For the time being, relevant endoscopic methods include intra-gastric balloons, gastric partitioning (Endo-plication), and the metabolic field (Endo-barrier). Surgical novelties and basic research are also important contributors owing to their potential combination with endoscopy. Conditions have been listed for implementation of bariatric endoscopy, because innovation is risky, expensive, and faces ethical challenges. A scientific background is being built (e.g., hormonal studies). Some techniques require additional study, while others are not ready but should be priorities. Steps and goals include the search for conceptual similarities and the respect of an ethical frame. Minimally invasive bariatric techniques are not ready for prime time, but they are already being successful as re-do procedures. A time-frame for step-strategies can be defined, and more investments from the industry are mandatory.
Citations
Citations to this article as recorded by
Nutritional Management and Role of Multidisciplinary Follow-Up after Endoscopic Bariatric Treatment for Obesity Anuradha Negi, Ravishankar Asokkumar, Rajesh Ravi, Gontrand Lopez-Nava, Inmaculada Bautista-Castaño Nutrients.2022; 14(16): 3450. CrossRef
You Can’t Have One Without the Other: Innovation and Ethical Dilemmas in Gastroenterology and Hepatology Thomas Couri, Andrew Aronsohn Clinical Gastroenterology and Hepatology.2021; 19(10): 2015. CrossRef
The role of silent helicobacter pylori infection in intragastric ulcers induced by balloon insertion used for management of obesity Tamer Haydara, Ahmed M. Kabel, Ayman M. Elsaka Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2019; 13(1): 116. CrossRef
Novelties in the treatment of obesity Pavol Holéczy Medicína pro praxi.2019; 16(4): 259. CrossRef
Un nouveau ballon gastrique : le modèle avalable Elipse S. Kolmer, J. Dargent Obésité.2018; 13(1): 13. CrossRef
Commentaire sur l’éditorial de Laurent Brunaud J. Dargent Journal de Chirurgie Viscérale.2018; 155(1): 84. CrossRef
Managing the popularity of bariatric surgery in France, comments on the editorial by Laurent Brunaud J. Dargent Journal of Visceral Surgery.2018; 155(1): 87. CrossRef
Improvement of Body Composition and Quality of Life Following Intragastric Balloon Silvia Mansur Reimão, Maria Elizabeth Rossi da Silva, Gabriel Cairo Nunes, Luiz Henrique Mazzonetto Mestieri, Rosa Ferreira dos Santos, Eduardo Guimarães Hourneaux de Moura Obesity Surgery.2018; 28(6): 1806. CrossRef
Partie VII — La chirurgie bariatrique, sinon rien ? Fogel–Étude ICAPS (2008–2014) J. Dargent Obésité.2018; 13(4): 212. CrossRef
Endoscopic gastric plication for obesity: Where might it fit in the scheme of things? David E. Cummings, Philip R. Schauer Obesity.2017; 25(2): 284. CrossRef
Making sense of metabolic obesity and hedonic obesity Yi‐Hao Yu Journal of Diabetes.2017; 9(7): 656. CrossRef
Gastrointestinal Surgery and Endoscopy: Recent Trends in Competition and Collaboration György Baffy, P. Marco Fisichella Clinical Gastroenterology and Hepatology.2017; 15(6): 799. CrossRef
Medical devices for the treatment of obesity Phong Ching Lee, John Dixon Nature Reviews Gastroenterology & Hepatology.2017; 14(9): 553. CrossRef